← Open Payments lookup

LIANJIE DU: Open Payments

NPI 1255331385 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$869 in 28 payments from 5 companies in 2025. Trend: 2023 $857 · 2024 $874 · 2025 $869

Food & beverage: $869
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$433
Teva Pharmaceuticals USA, Inc.5$222
Janssen Pharmaceuticals, Inc3$93
E.R. Squibb & Sons, L.L.C.3$71
Otsuka America Pharmaceutical, Inc.3$50

Products named: INGREZZA, UZEDY, INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, AUSTEDO XR, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.